ACA Earnings Preview: Options Price a ±1.7% Move
· The NYC Memo · ACA reports 2026-10-29
Arcosa, Inc. reports October 29, 2026. The November 20, 2026 straddle implies ±1.71% against a 3.41% average reaction, with dealers long gamma and max pain at $150.
Arcosa, Inc. reports on October 29, 2026, with ACA trading at $149.15. The November 20, 2026 straddle costs $2.55, implying a move of 1.71% within a range of $146.60 to $151.70. This expectation is narrower than the average realised reaction of 3.41% across 4 prints counted. Across those prior releases, the share price closed higher 2 times and lower 2 times.
Dealer positioning shows a long gamma lean heading into the print. This dealer posture suggests market makers will damp volatility, anchoring the tape toward the $150 max pain strike. The put call oi is 1.05. The stock is up +1.8% over the past month and -0.0% from its high.
What the market will be watching
The desk is watching demand trends across public infrastructure and commercial construction projects. Traders will evaluate whether pricing power can offset raw material inflation, freight expenses, and labor costs to protect operating margins. Guidance for the remainder of the year will dictate positioning, specifically management commentary on volume commitments and backlog conversion rates. The market will also trade off cyclical trends in barge orders and utility structures, focusing closely on intake cadence, contract timing, and acquisition integration.
What the options market is pricing
| Measure | Level |
|---|---|
| October 29, 2026 | |
| Expiry used | November 20, 2026 (24 days out) |
| Spot | $149.15 |
| ATM straddle | $2.55 |
| Implied move | ±1.71% ($146.60 to $151.70) |
| ATM implied vol | 3.5% |
| Put/call open interest | 1.05 |
| Max pain | $150 |
| Net dealer gamma | +$12mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $150 (358 contracts) |
| Heaviest put strike below spot | $95 (80 contracts) |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ACA between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 5 | -0.30% |
| Q1 2026, Apr 30 | -1.35% |
| Q4 2025, Feb 24 | +1.40% |
| Q3 2025, Oct 30 | +10.57% |
Across the last 4 prints the average absolute reaction is 3.41%, with 2 higher and 2 lower. The best was +10.57% and the worst -1.35%. Options are asking ±1.71%, which is 1.70 points cheaper than the realised average, the premium buyer's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $149.15 |
| 52-week range | $91.40 to $149.21 |
| Position in that range | 100% |
| From the 52-week high | -0.0% |
| From the 52-week low | +63.2% |
| Past week | +1.5% |
| Past month | +1.8% |
| Past three months | +2.9% |
| 50-day average | $146.08 |
| 200-day average | $129.84 |
How the options market is pricing it
The November 20, 2026 straddle marks $146.60 to $151.70 as the range the options market is paying for into the print, with ATM implied vol at 4% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ACA has moved 3.41% on earnings against the ±1.71% now implied, so the market is pricing this print cheaper than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ACA before the print.
Data as of October 27, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ACA options memo